Efficacy of Aldara® (Imiquimod) for Treatment of Low-Risk Nodular ... - Cancer Consultants (press release)
Researchers from Germany have reported that Aldara® can eradicate 64% of low-risk nodular basal cell carcinomas. The details of this study were reported in ...